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In the past, the presence of >50% stenosis in an unprotected
left main (ULM) trunk had been classically considered a
“surgical” indication for revascularization, and only nonsur-
gical candidates would be considered for percutaneous coro-
nary intervention (PCI) (1). Optimized medical therapy
alone for severe stenosis at this location has not been recom-
mended as a standard procedure, regardless of the clinical
condition. With the evolution of technique and material,
PCI for ULM has now become an alternative, associated
with quite predictable and favorable long-term outcomes,
meriting an upgrade in guideline indications for myocardialSee pages 1242 and 1250revascularization (1–3). This has occurred due to more con-
temporary published data with drug-eluting stents (DES)
derived from large registries and randomized trials with pre-
speciﬁed subgroup analyses, which provided convincing
evidence of the feasibility and effectiveness of such a proce-
dure. A meta-analysis involving 3 randomized trials and 9
observational studies with 5,079 patients compared the
1-year outcomes of patients with ULM disease treated by
PCI with DES implantation versus coronary artery bypass
graft (CABG) surgery. Results demonstrated trends toward
a lower risk of death and the composite endpoint of death/
myocardial infarction/stroke in the PCI DES group (odds
ratio [OR]: 0.68; 95% conﬁdence interval [CI]: 0.45 to
1.02); however, target vessel revascularization (TVR) was
signiﬁcantly higher in the PCI DES group versus the CABG
surgery group (OR: 3.52; 95% CI: 2.72 to 4.56) (4). Such
outcomes appear to remain consistent over time (5–9). In
the multicenter DELTA registry, 2,775 patients with ULM
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contents of this paper to disclose.and CABG surgery (n ¼ 901), and at a mean follow-up of
w3.5 years, there were comparable outcomes in terms of the
occurrence of death/myocardial infarction/stroke (adjusted
hazard ratio [HR]: 1.11; 95% CI: 0.85 to 1.42), mortality
(adjusted HR: 1.16; 95% CI: 0.87 to 1.55) or death/
myocardial infarction (adjusted HR: 1.25; 95% CI: 0.95 to
1.64), but a signiﬁcant advantage of CABG was observed
for the composite endpoint of death/myocardial infarction/
stroke/TVR (major adverse cardiac and cerebrovascular
events [MACCE]) driven exclusively by lower rates of
TVR compared with PCI (adjusted HR: 1.64; 95% CI:
1.33 to 2.03) (9). Compared with CABG surgery, PCI has
been associated with increased vessel revascularization. With
DES implantation, this gap has decreased dramatically,
but more complex lesion morphology remains an important
predictor of recurrences. In the pre-speciﬁed left main cohort
of the SYNTAX (SYNergy between percutaneous coronary
intervention with TAXus and cardiac surgery) trial, there
were comparable 5-year outcomes for DES PCI versus
CABG surgery in terms of death (12.8% vs. 14.6%, p¼ 0.53),
cardiac death (8.6% vs. 7.2%, p ¼ 0.46), myocardial infarc-
tion (8.2% vs. 4.8%, p ¼ 0.10), and death/myocardial
infarction/stroke (19.0% vs. 20.8%, p ¼ 0.57) (10). How-
ever, PCI with DES implantation was associated with
signiﬁcantly lower rates of stroke (1.5% vs. 4.3%, p ¼ 0.03),
but signiﬁcantly higher rates of TVR (26.7% vs. 15.5%,
p < 0.01). When stratifying these outcomes according to
lesion complexity as assessed by the SYNTAX score, there
are comparable results in both low and intermediate scores,
but at the high score (>32), the rates of TVR were signiﬁ-
cantly higher with PCI with DES implantation versus
CABG surgery (34.1% vs. 11.6%, p < 0.001).
Hence, what do we need to know when planning ULM
PCI? First, the extent of the disease, whether restricted to
the ostium and mid-shaft or involving the distal bifurcation;
second, the angulation between distal branches, if involving
the distal bifurcation; third, the degree of mismatch between
proximal and distal segments; and fourth, lesion severity. In
this issue of the JACC: Cardiovascular Interventions, 2 studies
shed light on some of the issues and mechanisms associated
with PCI failure after DES implantation for ULM. In
a subanalysis of the DELTA registry reported by Naganuma
et al. (11), distal ULM disease was a signiﬁcant predictor
of major adverse cardiac events (MACCE) (death/myocar-
dial infarction/TVR) at follow-up. There were also trends
toward higher rates of death and death/myocardial infarction
with distal versus nondistal LM disease. In addition, double
stenting was associated with higher MACCE and TVR
rates compared with single stenting, regardless of the tech-
nique applied. Compared with nonbifurcation lesions, long-
term follow-up of bifurcation lesions, in general, shows
a relatively higher incidence of restenosis, especially at the
side branch ostial location (12). This appears to be the case
with ULM, because recurrences after PCI with DES
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1262implantation are frequently found at the left circumﬂex
ostium (13). In the study by Naganuma et al. (11), increased
MACE rates in ULM bifurcation lesions were mainly dri-
ven by TVR, but the anatomic location of the recurrences
was not provided. A substudy of the SYNTAX trial
reported by Girasis et al. (14) investigated the impact of
a 3-dimensional bifurcation angle on late outcomes of
patients with ULM undergoing PCI with DES implanta-
tion. A very interesting ﬁnding from this substudy was
that a post-PCI systolic-diastolic angle <10 between the
distal branches of the left main bifurcation, as measured by
3-dimensional dedicated quantitative coronary angiographic
analysis, was associated with worse 5-year clinical outcomes.
The ﬁndings of both studies illustrate the negative impact
of distal bifurcation disease and the complex approach to
bifurcation PCI in ULM. The use of the complex approach
with double stenting for coronary bifurcation PCI is a direct
marker of more complex disease (15). Thus, worse outcomes
in this subset are not surprisingly observed. Incomplete
lesion coverage, stent malaposition, and stent underexpan-
sion are frequently encountered with complex techniques and
explain, at least in part, the mechanisms of failure (12). Also,
the overall geometry of the coronary tree and the natural
dynamic of the bifurcation throughout the cardiac cycle may
play a role. Coronary bifurcations are likely the arterial regions
with the greatest movement, and those dynamic changes
in the relationship between the different segments occur
continuously (16). Thus, altering this geometry may lead to
sustained and repetitive stresses, which may cause excessive
injury to the vessel wall and stent fracture or recoil.
Ostial and mid-shaft lesions are relatively straightforward
procedures with predictable results. However, to optimize
the results in bifurcation ULM PCI, the issues pointed out
here need to be adequately assessed. For lesions without
signiﬁcant involvement of the side branch, the cross-left
circumﬂex artery technique with a single stent is the best
approach (6). For true bifurcation lesions with extensive and
severe disease involving both branches, a complex approach
with elective double stenting may be required. In this situ-
ation, an intravascular ultrasound-guided procedure and
proper determination of the angulation are critical for
selecting the ideal technique (17). These aspects help
continue the left main PCI journey toward maturity.
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